Kerrie McLaughlin is a Clinical Study Team Lead in Oncology Early Development who currently holds the position of Director at Pfizer. With a strong background in project management, Kerrie has led cross-functional clinical study teams on multinational clinical trials while ensuring compliance with regulatory standards. Kerrie's previous experience includes roles at Gilead Sciences and Seattle Genetics, where they managed global clinical trials in various therapeutic areas, including oncology and pulmonology. Kerrie holds a Bachelor of Science in Business Management from Western Governors University and an Associate of Science in Industrial and Product Design from the Art Institute of Seattle.
This person is not in the org chart
This person is not in any teams
This person is not in any offices